Orchestra BioMed Holdings, Inc. OBIO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 224.15% | 89.24% | 59.42% | 43.17% | -47.95% |
| Total Receivables | -38.55% | -5.62% | 3.26% | -54.78% | 3.75% |
| Inventory | 35.14% | 105.19% | 79.19% | 55.98% | 164.29% |
| Prepaid Expenses | -42.19% | -19.33% | -52.53% | 19.80% | 46.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 210.02% | 85.36% | 56.01% | 42.62% | -46.03% |
|
|
|||||
| Total Current Assets | 210.02% | 85.36% | 56.01% | 42.62% | -46.03% |
| Net Property, Plant & Equipment | 1.39% | -5.46% | -7.92% | 9.43% | 23.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.59% | -1.56% | 21.57% | -0.54% | 51.72% |
| Total Assets | 170.17% | 70.46% | 50.78% | 39.15% | -40.84% |
|
|
|||||
| Total Accounts Payable | 15.52% | 13.48% | 18.72% | 79.40% | -15.38% |
| Total Accrued Expenses | -1.79% | 22.29% | 62.56% | -2.80% | 57.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.86% | 33.05% | 36.55% | 76.20% | 83.43% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 14.34% | 22.02% |
| Total Other Current Liabilities | -- | -- | -- | 14.34% | 22.02% |
| Total Current Liabilities | -21.04% | -11.60% | 3.26% | 27.36% | 17.63% |
|
|
|||||
| Total Current Liabilities | -21.04% | -11.60% | 3.26% | 27.36% | 17.63% |
| Long-Term Debt | 142.21% | -0.03% | -0.17% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -60.84% | -51.85% | -44.52% | -21.34% | 20.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 283.83% | 92.96% | 77.16% | 119.20% | -22.88% |
| Total Liabilities | 102.87% | 17.77% | 19.12% | 109.86% | 50.51% |
|
|
|||||
| Common Stock & APIC | 22.44% | 22.88% | 21.39% | 21.38% | 8.01% |
| Retained Earnings | -16.96% | -16.63% | -17.01% | -25.57% | -25.04% |
| Treasury Stock & Other | -606.25% | -208.11% | 15.38% | -54.08% | 169.57% |
| Total Common Equity | 6,450.17% | 144.36% | 62.54% | -5.37% | -99.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6,450.17% | 144.36% | 62.54% | -5.37% | -99.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9,872.88% | 202.34% | 92.30% | -5.37% | -99.33% |
|
|
|||||